Parkinson's disease is not only the second most prevalent neurodegenerative disease after Alzheimer's disease, but also the fastest growing. With the number of cases steadily increasing, there is an urgent need for innovative therapeutic approaches. Scientists at the world-renowned Spaulding Rehabilitation...

Alzheimer’s disease (AD) continues to pose one of the greatest challenges in medicine, with progressive cognitive decline and limited treatment options. A recently published study by Cont et al., under the lead of Prof. Lars Wojtecki, explores the potential of Transcranial...

The newly released video publication on Transcranial Pulse Stimulation (TPS) for patients with Alzheimer’s disease by Cont et al., led by TPS expert and key opinion leader Prof. Lars Wojtecki, has recently been published by »Journal of Visualized Experiments (JoVE)« in the...

Alzheimer’s disease (AD) is clinically characterized by progressive cognitive decline, affecting memory, language, orientation, and behaviour. Neural oscillations, also known as brain waves, are integral to cognitive processes but become dysregulated in AD, contributing to network dysfunction and memory impairments. Targeting...